Studies a heart stent in people with narrowed coronary arteries
Compares the Coroflex ISAR NEO stent with other stents in routine care.
Plain-language title generated from the registry record
Registry title: IRIS-Coroflex NEO Cohort
Key facts
- Where
- Bucheon-si, Daegu, Gwangju, Ilsan, Sejong, Seoul, Suwon, and Uijeongbu-si, South KoreaSee the 11 sites
Where in South Korea
- Bucheon Sejong HospitalBucheon-si, South KoreaTaking people
- The Catholic Univ. of Korea Bucheon ST. Mary's HospitalBucheon-si, South KoreaTaking people
- Veterans HospitalDaegu, South KoreaTaking people
- Chonnam National University HospitalGwangju, South KoreaNot yet recruiting
- Inje University Ilsan Paik HospitalIlsan, South KoreaNot yet recruiting
- Myongji HospitalIlsan, South KoreaTaking people
- Sejong Chungnam National University HospitalSejong, South KoreaTaking people
- Asan Medical CenterSeoul, South KoreaTaking people
- Seoul National University Boramae Medical CenterSeoul, South KoreaNot yet recruiting
- The Catholic University of Korea St. Vincent's HospitalSuwon, South KoreaTaking people
- Uijeongbu Eulji Medical CenterUijeongbu-si, South KoreaNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Seung-Jung Park
- Trial code
- NCT06177743
- Record updated
- 25 June 2026
- Original description
The objective of this study is to evaluate the effectiveness and safety of Coroflex ISAR NEO stents in comparison to other drug-eluting stents (DES) in real-world practice.Read full original descriptionShow less
Evaluation of Effectiveness and Safety of Coroflex ISAR NEO Stent in Routine Clinical Practice; A Multicenter, Prospective Observational Study
The objective of this study is to evaluate the effectiveness and safety of Coroflex ISAR NEO stents in comparison to other drug-eluting stents (DES) in real-world practice.
Inclusion: Patients ≥ 19 years old; Patients receiving Coroflex ISAR NEO stents; The patient or guardian agrees to the study protocol and the schedule of clinical follow-up, and provides informed, written consent, as approved by the appropriate Institutional Review Board/Ethics Committee of the respective clinical site.
Exclusion: Terminal illness with life expectancy <1 year; Patients with a mixture of other DESs; Patients with cardiogenic shock.